About Neckepur
Onboarderd scientists, researchers & inventors
- Co-founders recognized pioneers in toxicology, pharmacology and regulatory science
- A multidisciplinary research team combining expertise in medecine, intensive care, toxicology,
- pharmacology, biomaterials, regulatory science & IT-AI developments
- Numerous Hospital & University partnerships: AP-HP, Necker & Lariboisière Hospitals,
- Paris-Cité University, St Joseph Foundation, Lille 3 University, CNRS, INSERM (U1008 & UMR S1144),…
Development supported by:
- a strategic committee
- a scientific committee
- a legal & regulatory task force
Prof. Frédéric Baud
Founder & Head of the Scientific Committee
Expert in clinical toxicology, with specific expertise in extracorporeal devices and antidotes.
- Professor of Intensive Care Medicine, Emeritus Professor, University Paris Diderot, since 1993
- Hospital practitioner, AP-HP 2014-2020
- Head of the Medical and Toxicological Intensive Care Unit Lariboisiere hospital 1995- 2014
- Developer of the patented method for drug–device interaction analysis, and major contributor to toxicodynetics in clinical toxicology
- Galien Award for pharmaceutical research on orphan drugs escaping
- conventional industrial development (Fomepizole 2001)
- Inventor of 2 patents (antidote drugs)
Anne Villepelet-Castot, MD
Founder & President
MD, Graduate in pharmacology and public health expert with a specialization in clinical pharmacology and regulation
- Advisor on care quality & safety vigilance and coordination for Regional Health Agency Ile-de-France from 2011 to 2015
- Head of risk management from 1994 to 2011 at the French Medicines Agency
- Former vice-president and president of the Pharmacovigilance group at the European Medicine Agency from 1999 to 2005